Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 27 articles:
HTML format
Text format



Single Articles


    October 2016
  1. HANLEY GE, McAlpine JN, Pearce CL, Miller D, et al
    The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Am J Obstet Gynecol. 2016 Oct 31. pii: S0002-9378(16)30971.
    PubMed     Text format     Abstract available


    August 2016
  2. MELAMED A, Keating NL, Clemmer JT, Bregar AJ, et al
    Laparoscopic Staging for Apparent Stage I Epithelial Ovarian Cancer: Analysis of the National Cancer Data Base.
    Am J Obstet Gynecol. 2016 Aug 24. pii: S0002-9378(16)30595.
    PubMed     Text format     Abstract available


    February 2016
  3. WRIGHT JD, Chen L, Tergas AI, Accordino M, et al
    Underuse of BRCA Testing in Patients with Breast and Ovarian Cancer.
    Am J Obstet Gynecol. 2016 Feb 11. pii: S0002-9378(16)00295.
    PubMed     Text format     Abstract available


    January 2016
  4. JERNIGAN A
    Reply.
    Am J Obstet Gynecol. 2016;214:139.
    PubMed     Text format    


    October 2015
  5. GUELI ALLETTI S, Bottoni C, Fanfani F, Gallotta V, et al
    Minimally Invasive Interval Debulking Surgery In Ovarian Neoplasm (MISSION Trial - NCT02324595): a feasibility study.
    Am J Obstet Gynecol. 2015 Oct 31. pii: S0002-9378(15)02227.
    PubMed     Text format     Abstract available


    September 2015
  6. UPALA S, Sanguankeo A
    Role of bariatric surgery in obese women with endometrial cancer risk.
    Am J Obstet Gynecol. 2015 Sep 22. pii: S0002-9378(15)01133.
    PubMed     Text format    


    August 2015
  7. STUCKEY AR, Onstad MA
    Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
    Am J Obstet Gynecol. 2015;213:161-5.
    PubMed     Text format     Abstract available


    June 2015
  8. SALANI R
    Neoadjuvant chemotherapy vs primary debulking surgery for advanced ovarian cancer. What is the debate regarding the ideal treatment: approach? age? or cost?
    Am J Obstet Gynecol. 2015;212:695-696.
    PubMed     Text format    


    May 2015
  9. KARP NE, Fenner DE, Burgunder-Zdravkovski L, Morgan DM, et al
    Removal of Normal Ovaries in Women Under Age 51 at the Time of Hysterectomy.
    Am J Obstet Gynecol. 2015 May 29. pii: S0002-9378(15)00539.
    PubMed     Text format     Abstract available


  10. JERNIGAN AM, Maurer KA, Cooper K, Schauer PR, et al
    Referring Survivors of Endometrial Cancer and Complex Atypical Hyperplasia to Bariatric Specialists: A Prospective Cohort Study.
    Am J Obstet Gynecol. 2015 May 13. pii: S0002-9378(15)00478.
    PubMed     Text format     Abstract available


    April 2015
  11. MIKHAIL E, Salemi JL, Mogos MF, Hart S, et al
    National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States 1998-2011.
    Am J Obstet Gynecol. 2015 Apr 29. pii: S0002-9378(15)00395.
    PubMed     Text format     Abstract available


    March 2015
  12. NEZHAT FR, Apostol R, Nezhat C, Pejovic T, et al
    New insights in the pathophysiology of ovarian cancer and implications for screening and prevention.
    Am J Obstet Gynecol. 2015 Mar 25. pii: S0002-9378(15)00325.
    PubMed     Text format     Abstract available


  13. MANTHA S, Sarasohn D, Ma W, Devlin SM, et al
    "Ovarian Vein Thrombosis After Debulking Surgery for Ovarian Cancer: Epidemiology and Clinical Significance"
    Am J Obstet Gynecol. 2015 Mar 2. pii: S0002-9378(15)00194.
    PubMed     Text format     Abstract available


    January 2015
  14. ROWLAND MR, Lesnock JL, Farris C, Kelley JL, et al
    Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced stage ovarian cancer in patients >/= 65 years old.
    Am J Obstet Gynecol. 2015 Jan 30. pii: S0002-9378(15)00109.
    PubMed     Text format     Abstract available


  15. BRISTOW RE, Chang J, Ziogas A, Gillen DL, et al
    Spatial Analysis of Advanced-Stage Ovarian Cancer Mortality in California.
    Am J Obstet Gynecol. 2015 Jan 30. pii: S0002-9378(15)00101.
    PubMed     Text format     Abstract available


  16. BENDIFALLAH S, Darai E
    Reply: To PMID 24949545.
    Am J Obstet Gynecol. 2015;212:116-7.
    PubMed     Text format    


  17. COLLINS GS
    Statistical flaws in the development of a prediction model.
    Am J Obstet Gynecol. 2015;212:116.
    PubMed     Text format    


    December 2014
  18. RAUH-HAIN JA, Foley OW, Winograd D, Andrade C, et al
    Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared to fallopian tube cancer.
    Am J Obstet Gynecol. 2014 Dec 13. pii: S0002-9378(14)02437.
    PubMed     Text format     Abstract available


  19. SUH-BURGMANN E, Hung YY, Kinney W
    Outcomes from ultrasound follow-up of small complex adnexal masses in women over 50.
    Am J Obstet Gynecol. 2014;211:623.
    PubMed     Text format     Abstract available


    October 2014
  20. LONG B, Chang J, Ziogas A, Tewari KS, et al
    Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
    Am J Obstet Gynecol. 2014 Oct 31. pii: S0002-9378(14)02196.
    PubMed     Text format     Abstract available


  21. LENGYEL E, Litchfield LM, Mitra AK, Nieman KM, et al
    Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.
    Am J Obstet Gynecol. 2014 Oct 19. pii: S0002-9378(14)01081.
    PubMed     Text format     Abstract available


    August 2014
  22. MAXWELL GL, Shoji Y, Darcy K, Litzi T, et al
    Micro RNAs in Endometrial Cancers from Black and White Patients.
    Am J Obstet Gynecol. 2014 Aug 28. pii: S0002-9378(14)00864.
    PubMed     Text format     Abstract available


  23. USACH I, Blansit K, Chen LM, Ueda S, et al
    Survival differences of serous tubal, ovarian, peritoneal and uterine carcinomas.
    Am J Obstet Gynecol. 2014 Aug 18. pii: S0002-9378(14)00847.
    PubMed     Text format     Abstract available


    July 2014
  24. SIMONS DE, Blansit MK, Tsuei MT, Brooks DR, et al
    Foreign vs. US Born Patients and The Association of Type I Uterine Cancer.
    Am J Obstet Gynecol. 2014 Jul 17. pii: S0002-9378(14)00706.
    PubMed     Text format     Abstract available


    June 2014
  25. BENDIFALLAH S, Canlorbe G, Raimond E, Hudry D, et al
    External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter study.
    Am J Obstet Gynecol. 2014 Jun 28. pii: S0002-9378(14)00638.
    PubMed     Text format     Abstract available


  26. RUTERBUSCH JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, et al
    The influence of comorbid conditions on racial disparities in endometrial cancer survival.
    Am J Obstet Gynecol. 2014 Jun 19. pii: S0002-9378(14)00609.
    PubMed     Text format     Abstract available


  27. BENDIFALLAH S, Ballester M, Uzan C, Fauvet R, et al
    Nomogram to predict the recurrence in patients with early and advanced stages of mucinous and serous borderline ovarian tumors.
    Am J Obstet Gynecol. 2014 Jun 17. pii: S0002-9378(14)00597.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: